Sign inJoin waitlistJoin the waitlist

DT

Deanna Teoh

Associate Professor · University of Minnesota

Credentials: · · · · · · ·

History

University of Minnesota
Present

Gynecologic Oncology
2009–2012
Obstetrics and Gynecology
2005–2009
Medical College of Wisconsin
2000–2004

Research

Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
Gynecologic Oncology · 2008 · 364 citations
Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cells
Oncotarget · 2016 · 116 citations
Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective…
Gynecologic Oncology · 2015 · 91 citations

Anne Blaes
22 papers
Melissa Geller
15 papers
Colleen Rivard
12 papers · 4 as a fellow
Emil Lou
12 papers
Lauren Thomaier
12 papers
Peter Argenta
9 papers
Angeles Secord
8 papers
LD
Levi Downs
8 papers
JH
Jane Hui
6 papers
Rahel Ghebre
6 papers
Elizabeth Michelson
5 papers · 1 as a fellow
Genevieve Melton-Meaux
5 papers

Grants

Optimizing Cervical Cancer Screening for HPV-Vaccinated Women: Evaluation of Post-Vaccination Cervical Cancer Screening Test
Agency for Healthcare Research and Quality · R03
Contact PI · $100K · University of Minnesota
2019–2021

Clinical trials

Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
Principal investigator · Active not recruiting
Masonic Cancer Center, University of Minnesota
2023–2026
Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
Principal investigator · Completed
Masonic Cancer Center, University of Minnesota
2015–2020
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
Site PI · Recruiting · Phase 1
GlaxoSmithKline
2024–2029
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Site PI · Recruiting
NRG Oncology
2020–2047